EVRYSDI pdr 0.75 mg/ml sol fl 80 ml + 1 ml ser
7680672510026
CH-67251
M09AX10
01.99.0.
Reimbursement limitations:
EVRYSDI.01
EVRYSDI ne peut être prescrit que par un médecin spécialiste en neurologie/neuropédiatrie dans des centres …
1 / 3
google
Details
- Product number
- 6725101
- CPT
- -
- Packaging group
- 80
- Unit
- ml
- Composition
- risdiplamum 60 mg, mannitolum, isomaltum 237.25 mg, aromatica (Erdbeere) cum maltodextrinum et E 1450, acidum tartaricum, natrii benzoas 30 mg, macrogolum 6000, sucralosum, E 300, dinatrii edetas, ad pulverem pro 2 g corresp. solutio reconstituta 80 ml corresp. natrium 7.21 mg corresp. risdiplamum 0.75 mg/1 ml.
Articles (1)
Evrysdi 0.75 mg/ml, Pulver zur Herstellung einer Lösung zum Einnehmen
Pulver zur Herstellung einer Lösung zum Einnehmen
80
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
60.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
237.25 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | AROMA |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
30.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | ANTON |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
7.21 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | WIZUS |
Reimbursement information
Public price
CHF 8471.35
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/12/2021
Authorization holder
Roche Pharma (Schweiz) AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 67251
- Drug name
- Evrysdi, Pulver zur Herstellung einer Lösung zum Einnehmen
- Galenic form
- PULO
- ATC Code
- M09AX10
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 06/05/2021
- Authorization expiration date
- 05/05/2026
- IT number
- 01.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- EVRYSDI pdr 0.75 mg/ml sol fl 80 ml + 1 ml ser
- Description (DE)
- EVRYSDI Pulv 0.75 mg/ml Lös Fl 80 ml + 1 ml Spr
- Market launch
- 06/05/2021
- Narcotic (BTM)
- No